These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Patterns of joint involvement at onset differentiate oligoarticular juvenile psoriatic arthritis from pauciarticular juvenile rheumatoid arthritis. Huemer C; Malleson PN; Cabral DA; Huemer M; Falger J; Zidek T; Petty RE J Rheumatol; 2002 Jul; 29(7):1531-5. PubMed ID: 12136915 [TBL] [Abstract][Full Text] [Related]
15. Early disease course and predictors of disability in juvenile rheumatoid arthritis and juvenile spondyloarthropathy: a 3 year prospective study. Selvaag AM; Lien G; Sørskaar D; Vinje O; Førre Ø; Flatø B J Rheumatol; 2005 Jun; 32(6):1122-30. PubMed ID: 15940778 [TBL] [Abstract][Full Text] [Related]
16. [Sandimmun-Neoral--a new quality of life for patients with severe systemic juvenile rheumatoid arthritis]. Alekseeva EI; Shakhbazian IE Ter Arkh; 1999; 71(5):26-9. PubMed ID: 10399226 [TBL] [Abstract][Full Text] [Related]
17. Etanercept therapy in children with juvenile rheumatoid arthritis. Hung JJ; Huang JL J Microbiol Immunol Infect; 2005 Dec; 38(6):444-6. PubMed ID: 16341346 [TBL] [Abstract][Full Text] [Related]
18. Fibrin D-dimer as a marker of disease activity in systemic onset juvenile rheumatoid arthritis. Bloom BJ; Tucker LB; Miller LC; Schaller JG J Rheumatol; 1998 Aug; 25(8):1620-5. PubMed ID: 9712110 [TBL] [Abstract][Full Text] [Related]
19. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis. Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593 [TBL] [Abstract][Full Text] [Related]